Colorectal cancer is the third most commonly diagnosed cancer worldwide and the second leading cause of cancer death, yet one ...
Accent Therapeutics, a clinical-stage biopharmaceutical company pioneering novel small molecule precision cancer therapies, ...
Preclinical data demonstrate enhanced efficacy of PLT012 in pMMR colorectal cancer models - Findings position CD36 as a promising metabolic checkpoint target in an underserved patient population DOVER ...
Physiologically Based Pharmacokinetic Model to Assess the Drug-Drug-Gene Interaction Potential of Belzutifan in Combination With Cyclin-Dependent Kinase 4/6 Inhibitors A total of 14,177 patients were ...
Colorectal cancer often returns not because the main tumor survives, but because a small population of stem-like cancer cells ...
More than 35,000 men in the United States die from prostate cancer each year. Now, a new study reveals the immune cell ...
Researchers at The University of Texas MD Anderson Cancer Center have discovered a new blood-based biomarker that can help ...
The findings revealed a shocking truth: High-fat diets are linked to aggressive breast cancer. More importantly, high-fat ...
Khaberni - The human intestine harbors over 100 trillion microorganisms, performing functions far beyond digestion, extending ...